• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因治疗的最新进展:直击问题根源的基因子弹。

Recent advances in gene therapy: genetic bullets to the root of the problem.

机构信息

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Clin Exp Med. 2023 Aug;23(4):1107-1121. doi: 10.1007/s10238-022-00925-x. Epub 2022 Oct 25.

DOI:10.1007/s10238-022-00925-x
PMID:36284069
Abstract

Genetics and molecular genetic techniques have changed many perspectives and paradigms in medicine. Using genetic methods, many diseases have been cured or alleviated. Gene therapy, in its simplest definition, is application of genetic materials and related techniques to treat various human diseases. Evaluation of the trends in the field of medicine and therapeutics clarifies that gene therapy has attracted a lot of attention due to its powerful potential to treat a number of diseases. There are various genetic materials that can be used in gene therapy such as DNA, single- and double-stranded RNA, siRNA and shRNA. The main gene editing techniques used for in vitro and in vivo gene modification are ZNF, TALEN and CRISPR-Cas9. The latter has increased hopes for more precise and efficient gene targeting as it requires two separate recognition sites which makes it more specific and can also cause rapid and sufficient cleavage within the target sequence. There must be carriers for delivering genes to the target tissue. The most commonly used carriers for this purpose are viral vectors such as adenoviruses, adeno-associated viruses and lentiviruses. Non-viral vectors consist of bacterial vectors, liposomes, dendrimers and nanoparticles.

摘要

遗传学和分子遗传技术已经改变了医学的许多观点和范例。利用遗传方法,许多疾病已经得到治愈或缓解。基因治疗的最简单定义是应用遗传物质和相关技术来治疗各种人类疾病。评估医学和治疗学领域的趋势表明,由于其治疗多种疾病的强大潜力,基因治疗引起了广泛关注。有多种遗传物质可用于基因治疗,如 DNA、单链和双链 RNA、siRNA 和 shRNA。用于体外和体内基因修饰的主要基因编辑技术有 ZNF、TALEN 和 CRISPR-Cas9。后者增加了对更精确和高效基因靶向的希望,因为它需要两个单独的识别位点,这使其更具特异性,并且还可以在靶序列内迅速且充分地切割。必须有载体将基因递送到靶组织。为此目的最常用的载体是病毒载体,如腺病毒、腺相关病毒和慢病毒。非病毒载体包括细菌载体、脂质体、树枝状聚合物和纳米颗粒。

相似文献

1
Recent advances in gene therapy: genetic bullets to the root of the problem.基因治疗的最新进展:直击问题根源的基因子弹。
Clin Exp Med. 2023 Aug;23(4):1107-1121. doi: 10.1007/s10238-022-00925-x. Epub 2022 Oct 25.
2
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
3
Delivery of CRISPR/Cas9 for therapeutic genome editing.CRISPR/Cas9 基因编辑治疗的递送。
J Gene Med. 2019 Jul;21(7):e3107. doi: 10.1002/jgm.3107.
4
Non-viral strategies for delivering genome editing enzymes.非病毒策略用于递送基因组编辑酶。
Adv Drug Deliv Rev. 2021 Jan;168:99-117. doi: 10.1016/j.addr.2020.09.004. Epub 2020 Sep 12.
5
Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.联合病毒转导和 CRISPR/Cas9 基因编辑治疗神经退行性疾病的治疗潜力。
Neurol Sci. 2018 Nov;39(11):1827-1835. doi: 10.1007/s10072-018-3521-0. Epub 2018 Aug 3.
6
Therapeutic Genome Editing and In Vivo Delivery.治疗性基因组编辑与体内递送。
AAPS J. 2021 Jun 2;23(4):80. doi: 10.1208/s12248-021-00613-w.
7
Progress of delivery methods for CRISPR-Cas9.CRISPR-Cas9 递送方法的研究进展。
Expert Opin Drug Deliv. 2022 Aug;19(8):913-926. doi: 10.1080/17425247.2022.2100342. Epub 2022 Jul 17.
8
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.CRISPR/Cas 基因组编辑组件的眼部递送来治疗眼部疾病。
Adv Drug Deliv Rev. 2021 Jan;168:181-195. doi: 10.1016/j.addr.2020.06.011. Epub 2020 Jun 27.
9
The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.CRISPR/Cas9 基因组编辑技术在抗击人类致癌病毒中的意义。
J Med Virol. 2019 Jan;91(1):1-13. doi: 10.1002/jmv.25292. Epub 2018 Sep 24.
10
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.用于治疗性基因编辑的CRISPR/Cas9体内递送:进展与挑战
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.

引用本文的文献

1
Gene therapy for genetic diseases: challenges and future directions.用于治疗遗传疾病的基因疗法:挑战与未来方向。
MedComm (2020). 2025 Feb 13;6(2):e70091. doi: 10.1002/mco2.70091. eCollection 2025 Feb.
2
Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update.儿童癌症基因治疗策略的进展与挑战:全面更新
Front Mol Biosci. 2024 May 21;11:1382190. doi: 10.3389/fmolb.2024.1382190. eCollection 2024.
3
Artificial Intelligence and Computational Biology in Gene Therapy: A Review.基因治疗中的人工智能与计算生物学:综述

本文引用的文献

1
Dissecting miRNA-Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine.解析 miRNA-基因网络,为心血管精准医学中基于药物基因组学指导的治疗决策的临床应用价值绘制路线图。
Cells. 2022 Feb 10;11(4):607. doi: 10.3390/cells11040607.
2
Pricing Zolgensma - the world's most expensive drug.诺西那生钠注射液定价——全球最昂贵的药物。 (注:Zolgensma是治疗脊髓性肌萎缩症的药物,中文名为诺西那生钠注射液,但原英文文本未明确指出,按照要求直接翻译。)
J Mark Access Health Policy. 2021 Dec 29;10(1):2022353. doi: 10.1080/20016689.2021.2022353. eCollection 2022.
3
Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery.
Biochem Genet. 2025 Apr;63(2):960-983. doi: 10.1007/s10528-024-10799-1. Epub 2024 Apr 18.
4
Recent advances in nanomaterial-based drug delivery systems for melanoma therapy.用于黑色素瘤治疗的基于纳米材料的药物递送系统的最新进展。
ADMET DMPK. 2023 Oct 24;12(1):107-150. doi: 10.5599/admet.2088. eCollection 2024.
5
Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape.构建 m6A 和中性粒细胞胞外诱捕网相关 lncRNA 模型预测肝细胞癌预后和免疫图谱。
Front Immunol. 2023 Oct 5;14:1231543. doi: 10.3389/fimmu.2023.1231543. eCollection 2023.
6
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges.基于小干扰 RNA(siRNA)的抗病毒治疗应用:原理、潜力和挑战。
J Biomed Sci. 2023 Oct 16;30(1):88. doi: 10.1186/s12929-023-00981-9.
基于细菌的癌症治疗:一种新兴的靶向药物/基因传递工具盒。
Biomaterials. 2021 Oct;277:121124. doi: 10.1016/j.biomaterials.2021.121124. Epub 2021 Sep 10.
4
Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.艰难梭菌 I-B 型 CRISPR-Cas 干扰和适应过程中的间隔区邻近基序特异性。
mBio. 2021 Aug 31;12(4):e0213621. doi: 10.1128/mBio.02136-21. Epub 2021 Aug 24.
5
Drug resistance and combating drug resistance in cancer.癌症中的耐药性与抗耐药性
Cancer Drug Resist. 2019;2(2):141-160. doi: 10.20517/cdr.2019.10. Epub 2019 Jun 19.
6
The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.癌细胞扩散机制作为免疫抑制微环境:癌症免疫治疗时代的新障碍。
Front Immunol. 2021 Apr 13;12:654877. doi: 10.3389/fimmu.2021.654877. eCollection 2021.
7
Helping Manufacturers Navigate Novel Coronavirus Variants.帮助制造商应对新型冠状病毒变种。
JAMA. 2021 Mar 16;325(11):1032. doi: 10.1001/jama.2021.3006.
8
Efficient gene targeting in Nicotiana tabacum using CRISPR/SaCas9 and temperature tolerant LbCas12a.利用 CRISPR/SaCas9 和温度耐受 LbCas12a 实现烟草中的高效基因靶向。
Plant Biotechnol J. 2021 Jul;19(7):1314-1324. doi: 10.1111/pbi.13546. Epub 2021 Jan 28.
9
Newcastle Disease Virus at the Forefront of Cancer Immunotherapy.新城疫病毒在癌症免疫治疗前沿领域
Cancers (Basel). 2020 Nov 28;12(12):3552. doi: 10.3390/cancers12123552.
10
NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma.NEAT1 多聚 A 调节反义寡核苷酸揭示了长非编码 RNA 异构体在神经母细胞瘤中的相反功能。
Cell Mol Life Sci. 2021 Mar;78(5):2213-2230. doi: 10.1007/s00018-020-03632-6. Epub 2020 Sep 10.